ID   HFB-1
AC   CVCL_6257
SY   HFB1; Human Fusion B cell-1
DR   Wikidata; Q54883251
RX   PubMed=3106068;
RX   PubMed=6126667;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=HFB-1
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 10-12 hours (PubMed=6126667).
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
RX   PubMed=3106068; DOI=10.1002/eji.1830170416;
RA   Shields J.G., Smith S.H., Levinsky R.J., DeFrance T., de Vries J.E.,
RA   Banchereau J., Callard R.E.;
RT   "The response of selected human B cell lines to B cell growth and
RT   differentiation factors.";
RL   Eur. J. Immunol. 17:535-540(1987).
//
RX   PubMed=6126667; DOI=10.1016/S0140-6736(82)92682-4;
RA   Hunter K.W. Jr., Hemming V.G., Fischer G.W., Wilson S.R.,
RA   Hartzman R.J., Woody J.N.;
RT   "Antibacterial activity of a human monoclonal antibody to Haemophilus
RT   influenzae type B capsular polysaccharide.";
RL   Lancet 320:798-799(1982).
//